Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by xqxon May 30, 2014 6:37am
301 Views
Post# 22613457

Another Moriarty article

Another Moriarty article"With the TheraLASE PDT in these mice treated, some sort of immunity or memory response was created by use of the PDC and laser light. That came as a giant surprise to everyone involved. It suggests the possibility of creating an affordable and practical vaccine to prevent cancer recurrence.
Need I remind our readers how valuable a vaccine to cure a cancer would be? Roger Dumoulin-White, President and CEO of TheraLASE describes the implications of this discovery as a game changer.
I’d say he has that exactly right."

https://www.321gold.com/editorials/moriarty/moriarty053014.html

Might lead to some new US-investors seeking an entry...
Bullboard Posts